Suppression of growth hormone by oral glucose in the evaluation of tall stature

Hormone Research

Volumn 51, Issue 1, 1999, Pages 20-24

  Holl, Reinhard ^a   Bucher, Peter ^b   Sorgo, Wolfgang ^b   Heinze, Eberhard ^b   Homoki, Janos ^b   Debatin, Klaus Michael ^b  

^a UNIVERSITY HOSPITAL GIESSEN   (Germany)

^b NONE

Author keywords

Eosinophilic pituitary adenoma; Growth hormone; Growth hormone excess; Oversecretion; Pituitary gigantism

Indexed keywords

GLUCOSE; GROWTH HORMONE; INSULIN;

ADOLESCENT; ARTICLE; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; FEMALE; GLUCOSE BLOOD LEVEL; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HORMONE INHIBITION; HUMAN; HYPOPHYSIS ADENOMA; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; SCHOOL CHILD; TALL STATURE;

EID: 0032890679     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000023308     Document Type: Article

References (38)

1. Gelber SJ, Heffez DS; Donohoue PA: Pituitary gigantism caused by growth hormone excess from infancy. J Pediatr 1992;120:931-934.
2. Lu PW, Silink M, Johnston I, Cowell CT, Jimenez M: Pituitary gigantism. Arch Dis Child 1992;67:1039-1041.
3. Blumberg DL, Sklar CA, David R, Rothenberg S, Bell J: Acromegaly in an infant. Pediatrics 1989;83:998-1002.
4. Perheentupa J, Somersalo H, Perkonen R: Patients with acromegaly come from tall families. Acta Endocrinol Suppl (Copenh) 1986;279: 174-177.
5. Jones MK, Evans PJ, Jones IR, Thomas JP: Familial acromegaly. Clin Endocrinol 1984;20: 355-358.
6. Melmed S; Acromegaly. N Engl J Med 1990; 322:966-977.
7. Frisch H, Häusler G: Diagnosis of growth hormone excess and hyperprolactinemia; in Ranke MB (ed): Diagnostic of Endocrine Function in Children and Adolescents, ed 2. Heidelberg, 1986, pp 219-229.
8. Sorgo W, Teller MW: Diagnostik and Therapie des Grosswuchses. Klin Pädiatr 1987:199:63-69.
9. Daughaday WH: Pituitary gigantism. Endocrinol Metab Clin NA 1992;21:633-647.
10. Blizzard RM, Johansson A: Disorders of growth; in Kappy MS, Blizzard RM, Migeon CJ (eds): Wilkins: The Diagnosis and Treatment of Endocrine Disorders in Childhood and Adolescence, ed 4. Springfield, Thomas, 1994, pp 383-433.
11. Thorner MO, Vance ML, Horvath E, Kovacs K: The anterior pituitary; in Wilson JD, Foster DW (eds): Williams Textbook of Endocrinology, ed 8. Philadelphia, Saunders, 1992, pp 221-310.
12. Prader A, Largo RH, Molinari L, Issler C: Physical growth of Swiss children from birth to 20 years of age. Helv Paediatr Acta 1989;52: 1-125.
13. Ho KKY, Weissberger AJ: Characterization of 24-hour growth hormone secretion in acromegaly: Implications for diagnosis and therapy. Clin Endocrinol 1994;41:75-83.
14. Hartman ML, Pincus SM, Johnson ML, Matthews DH, Faunt LM, Vance ML, Thorner MO, Veldhuis JD: Enhanced basal and disorderly growth hormone secretion distinguish acromegalic from normal pulsatile GH release. J Clin Invest 1994;94:1277-1288.
15. Mimis RB, Bethune JE: Acromegaly with normal fasting growth hormone concentrations but abnormal growth hormone regulation. Ann Intern Med 1974;81:781-784.
16. Yoshida T, Shimatsu A, Sakane N, Hizuka N, Horikawa R. Tanaka T: Growth hormone secretory dynamics in a case of acromegalic gigantism associated with hyperprolactinemia: Nonpulsatile secretion of GH may induce elevated insulin-like growth factor-I and IGF-binding protein-3 levels. J Clin Endocrinol Metab 1996;81:310-313.
17. Melmed S, Ho K, Klibanski A, Reichlin S, Throner M: Recent advances in pathogenesis, diagnosis and management of acromegaly. J Clin Endocrinol Metab 1995;80:3395-3402.
18. Jaffe CA, Barkan AL: Acromegaly: Recognition and treatment. Drugs 1994;47:425-445.
19. Deutsche Gesellschaft für Endokrinologie: Rationelle Diagnostik in der Endokrinologie. New York, Thieme, 1993, pp 9-12.
20. Barth JH, Smith JH, Clarkson P: Wide diversity in measurements of GH after stimulation tests in short children are due to assay variability. Ann Clin Biochem 1995;32:369-372.
21. Chevenne D, Beau N, Leger J, Porquet D: Variability of serum human growth hormone levels in different commercial assays. Horm Res 1993;40:168-172.
22. Chapman IM, Hartman ML, Straume M; Johnson ML, Veldhuis JD, Thorner MO: Enhanced sensitivity GH chemiluminescence assay reveals lower postglucose nadir GH concentrations in men than women. J Clin Endocrinol Metab 1994;78:1312-1319.
23. Sharp PS, Foley K, Chahal P, Kohner EM: The effect of plasma glucose on the growth hormone response to human pancreatic growth hormone releasing factor in normal subjects. Clin Endocrinol 1984;20:497-501.
24. Davies RR, Turner S, Johnston DG: Oral glucose inhibits growth hormone secretion induced by human pancreatic growth hormone releasing factor 1-44 in normal man. Clin Endocrinol 1984;21:477-481.
25. Masuda A, Shibasaki T, Nakahara M, Imaki T, Kiyosawa Y, Jibiki K, Demura H, Shizume K, Ling N: The effect of glucose on growth hormone (GH)-releasing hormone-mediated GH secretion in man. J Clin Endocrinol Metab 1985;60:523-526.
26. Penalva A, Burguera B, Casabiell X, Tresguerras JA, Dieguez C, Casanueva FF: Activation of cholinergic neurotransmission by pyridostigmine reverses the inhibitory effect of hyperglycemia on growth hormone releasing hormone-induced GH secretion in man. Neuroendocrinology 1989;49:551-554.
27. Horton ES, Johnson C, Lebovitz HE: Carbohydrate metabolism in uremia. Ann Intern Med 1968;68:63-74.
28. Becker MD, Cook GC, Wright AD: Paradoxical elevation of growth hormone in active chronic hepatitis, Lancet 1969;ii:1035-1039.
29. Vinik A, Pimstone B, Buchanan-Lee B: Impairment of hyperglycemia induced growth hormone suppression in hyperthyroidism. J Clin Endocrinol Metab 1968;28:1534-1538.
30. Pieters GFFM, Smals AGH, Kloppenborg PWC: Defective suppression of growth hormone after oral glucose loading in adolescence. J Clin Endocrinol Metab 1980;51:265-270.
31. Evain-Brion D, Garnier P, Schimpff RM, Chaussain JL, Job JC: Growth hormone response to thyrotropin-releasing hormone and oral glucose-loading tests in tall children and adolescents. J Clin Endocrinol Metab 1983;56: 429-432.
32. Maccario M, Procopio M, Grottoli S, Oleandri SE, Razzore P, Camanni F, Ghigo E: In obesity the somatotrope response to GHRH or arginine is inhibited by somatostatin or pirenzepine but not by oral glucose load. J Clin Endocrinol Metab 1995;80:3774-3778.
33. Grottoli S, Procopio M, Maccario M, Zini M, Oleandri SE, Tassone F, Valcavi R, Ghigo E: In obesity, glucose load loses its early inhibitory, but maintains its late stimulatory, effect on somatotrope secretion. J Clin Endocrinol Metab 1997;82:2261-2265.
34. Rieu M, Kuhn JM, Bricaire H, Luton JP: Evaluation of treated acromegalic patients with normal growth hormone levels during oral glucose load. Acta Endocrinol 1984; 107:1-8.
35. Pieters GFFM, Hermus ARMM, Smals AGH, Kloppenborg PWC: Paradoxical responsiveness of growth hormone to corticotropin-releasing factor in acromegaly. J Clin Endocrinol Metab 1984;58:560-562.
36. Rieu M, Girard F, Bricaire H, Binoux M: The importance of IGF measurements in the diagnosis and surveillance of acromegaly. J Clin Endo Metab 1982;55:147-153.
37. Underwood LE: Clinical relevance of somatomedin; in Lifshitz F (ed): Pediatric Endocrinology. New York, Marcel Dekker, 1985, pp 37-59.
38. Pholsena M, LeBouc Y, Rousseau E, Christol R, Birman P, Perin L, Girard F: Evaluation of acromegaly by measurement of 24-hourly urinary growth hormone excretion. Acta Endocrinol 1993;1128:9-14.